Literature DB >> 9431607

Transfusion management in pediatric and adolescent scoliosis surgery. Efficacy of autologous blood.

D J Murray1, R B Forbes, M B Titone, S L Weinstein.   

Abstract

STUDY
DESIGN: A retrospective review of consecutive pediatric and adolescent patients who required posterior spinal fusion to correct scoliosis.
OBJECTIVES: To 1) measure the participation of pediatric patients in predeposit programs for autologous and directed blood donation 2) to assess the success of autologous predonation in preventing allogeneic blood use, 3) to determine whether transfusion indications differed between patients who received allogeneic blood and those who received autologous blood, and 4) to assess factors that predict transfusion requirements during scoliosis surgery. SUMMARY OF BACKGROUND DATA: Authors of recent studies in adults have questioned whether transfusion of autologous blood is a cost-effective therapy when compared with the less-expensive alternative--transfusion of allogeneic blood. In children, the efficacy of autologous blood has not been assessed in a large population of surgical patients. In adults, the frequency of patient participation, the success of autologous donors in avoiding allogeneic transfusion, and the proportion of collected autologous units used during the perioperative period are measures used to establish the efficacy of autologous predonation programs.
METHODS: Hospital and clinic records for each patient who underwent posterior spinal fusion from September 1, 1989 through September 1, 1994 were reviewed. Blood bank consultation, autologous donation records, anesthesia records, surgical reports, and hospital records were reviewed. Seventy percent of patients (164 of 243) participated in autologous donation.
RESULTS: More than 90% of autologous donors successfully avoided receiving allogeneic blood. Patients with idiopathic scoliosis (n = 168) were more likely to participate in autologous donation (n = 144) and to avoid allogeneic blood (n = 135). Patients with neurologic causes of scoliosis more commonly used allogeneic or directed donation (56 of 75 patients). Nineteen patients with neuromuscular causes of scoliosis participated in autologous donation, but more than one half of this group (10 of 19 patients) required allogeneic blood in addition to autologous units.
CONCLUSIONS: Using measures of efficacy similar to those reported in studies of adults, autologous blood was found to be more effective in meeting the transfusion needs of pediatric patients who required posterior spinal fusion than in meeting those needs in adult surgical patients in previous studies.

Entities:  

Mesh:

Year:  1997        PMID: 9431607     DOI: 10.1097/00007632-199712010-00007

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  11 in total

Review 1.  Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

Authors:  M Muñoz; J J García-Vallejo; M D Ruiz; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2004-05-08       Impact factor: 3.134

2.  Comparing results of posterior spine fusion in patients with AIS: Are two surgeons better than one?

Authors:  Matthew A Halanski; Corey M Elfman; Jeffrey A Cassidy; Nabil E Hassan; Sarah A Sund; Kenneth J Noonan
Journal:  J Orthop       Date:  2013-06-15

3.  Eliminating the use of allogeneic blood products in adolescent idiopathic scoliosis surgery.

Authors:  Mark J Berney; Peter H Dawson; Margaret Phillips; Darren F Lui; Paul Connolly
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-03-27

4.  Single vs two attending senior surgeons: assessment of intra-operative blood loss at different surgical stages of posterior spinal fusion surgery in Lenke 1 and 2 adolescent idiopathic scoliosis.

Authors:  Mun Keong Kwan; Chee Kidd Chiu; Chris Yin Wei Chan
Journal:  Eur Spine J       Date:  2016-10-12       Impact factor: 3.134

5.  One-step (standard) versus two-step surgical approach in adolescent idiopathic scoliosis posterior spinal fusion: Which is better?

Authors:  Norman Ramirez; Pablo Valentin; Manuel García-Cartagena; Solais Samalot; Ivan Iriarte
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-05-13

6.  Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?

Authors:  Maciej Kolban; Ina Balachowska-Kosciolek; Michal Chmielnicki
Journal:  Eur Spine J       Date:  2005-08-17       Impact factor: 3.134

7.  Predeposit autologous donation in spinal surgery: a multicentre study.

Authors:  José A García-Erce; Manuel Muñoz; Elvira Bisbe; Montserrat Sáez; Víctor Manuel Solano; Sandra Beltrán; Aina Ruiz; Jorge Cuenca; Javier Vicente-Thomas
Journal:  Eur Spine J       Date:  2004-07-06       Impact factor: 3.134

Review 8.  Preoperative erythropoietin in spine surgery.

Authors:  Maria J Colomina; Juan Bagó; Ferran Pellisé; Carmen Godet; Carlos Villanueva
Journal:  Eur Spine J       Date:  2004-06-09       Impact factor: 3.134

Review 9.  Acute normovolemic hemodilution.

Authors:  David Murray
Journal:  Eur Spine J       Date:  2004-06-10       Impact factor: 3.134

10.  Effectiveness of preoperative autologous blood donation for protection against allogeneic blood exposure in adult spinal deformity surgeries: a propensity-matched cohort analysis.

Authors:  Michael P Kelly; Lukas P Zebala; Han Jo Kim; Daniel M Sciubba; Justin S Smith; Christopher I Shaffrey; Shay Bess; Eric Klineberg; Gregory Mundis; Douglas Burton; Robert Hart; Alex Soroceanu; Frank Schwab; Virginie Lafage
Journal:  J Neurosurg Spine       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.